Keith B. Ryther

934 total citations
16 papers, 673 citations indexed

About

Keith B. Ryther is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Keith B. Ryther has authored 16 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Pharmacology and 8 papers in Organic Chemistry. Recurrent topics in Keith B. Ryther's work include Nicotinic Acetylcholine Receptors Study (14 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Synthesis and Biological Evaluation (6 papers). Keith B. Ryther is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (14 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Synthesis and Biological Evaluation (6 papers). Keith B. Ryther collaborates with scholars based in United States, United Kingdom and Denmark. Keith B. Ryther's co-authors include Mark W. Holladay, David J. Anderson, Stephen P. Arnerić, Diana L. Donnelly‐Roberts, Michael Buckley, James P. Sullivan, Jeffrey E. Campbell, Michael Decker, Nan‐Horng Lin and Richard L. Elliott and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Keith B. Ryther

16 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith B. Ryther United States 12 566 208 207 125 56 16 673
Marietta Piattoni-Kaplan United States 8 715 1.3× 232 1.1× 178 0.9× 153 1.2× 67 1.2× 9 783
James T. Wasicak United States 14 754 1.3× 251 1.2× 401 1.9× 110 0.9× 83 1.5× 20 937
Ashok Tehim United States 11 332 0.6× 156 0.8× 172 0.8× 170 1.4× 102 1.8× 27 587
Terry A. Hauser United States 12 468 0.8× 152 0.7× 137 0.7× 98 0.8× 32 0.6× 19 628
Christopher G. V. Sharples United Kingdom 10 564 1.0× 121 0.6× 131 0.6× 237 1.9× 28 0.5× 12 665
Agripina G. Deaciuc United States 14 365 0.6× 86 0.4× 214 1.0× 196 1.6× 30 0.5× 31 598
Anatoly Mazurov United States 13 421 0.7× 136 0.7× 146 0.7× 72 0.6× 36 0.6× 24 612
William Glassco United States 8 363 0.6× 77 0.4× 90 0.4× 151 1.2× 60 1.1× 8 429
Vladimir P. Grinevich United States 13 336 0.6× 68 0.3× 97 0.5× 168 1.3× 20 0.4× 24 450
Brian J. Lavey United States 14 241 0.4× 300 1.4× 122 0.6× 187 1.5× 29 0.5× 19 585

Countries citing papers authored by Keith B. Ryther

Since Specialization
Citations

This map shows the geographic impact of Keith B. Ryther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith B. Ryther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith B. Ryther more than expected).

Fields of papers citing papers by Keith B. Ryther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith B. Ryther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith B. Ryther. The network helps show where Keith B. Ryther may publish in the future.

Co-authorship network of co-authors of Keith B. Ryther

This figure shows the co-authorship network connecting the top 25 collaborators of Keith B. Ryther. A scholar is included among the top collaborators of Keith B. Ryther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith B. Ryther. Keith B. Ryther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nelson, Derek W., Jennifer M. Frost, Karin Tietje, et al.. (2012). Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB2 receptor agonists for pain management. Bioorganic & Medicinal Chemistry Letters. 22(7). 2604–2608. 10 indexed citations
2.
Li, Tao, William H. Bunnelle, Keith B. Ryther, et al.. (2010). Syntheses and structure–activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel α7 neuronal nicotinic receptor (NNR) ligands. Bioorganic & Medicinal Chemistry Letters. 20(12). 3636–3639. 10 indexed citations
3.
Bunnelle, William H., Jerome F. Daanen, Keith B. Ryther, et al.. (2007). Structure−Activity Studies and Analgesic Efficacy ofN-(3-Pyridinyl)-Bridged Bicyclic Diamines, Exceptionally Potent Agonists at Nicotinic Acetylcholine Receptors. Journal of Medicinal Chemistry. 50(15). 3627–3644. 44 indexed citations
4.
Dart, Michael J., James T. Wasicak, Keith B. Ryther, et al.. (2000). Structural aspects of high affinity ligands for the α4β2 neuronal nicotinic receptor. Pharmaceutica Acta Helvetiae. 74(2-3). 115–123. 29 indexed citations
5.
Decker, Michael, Anthony W. Bannon, Michael Buckley, et al.. (1998). Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice. European Journal of Pharmacology. 346(1). 23–33. 51 indexed citations
6.
Lin, Nan‐Horng, David Gunn, Yihong Li, et al.. (1998). Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist. Bioorganic & Medicinal Chemistry Letters. 8(3). 249–254. 35 indexed citations
7.
Lynch, J.A., Mark W. Holladay, Keith B. Ryther, et al.. (1998). Efficient asymmetric synthesis of ABT-594; a potent, orally effective analgesic. Tetrahedron Asymmetry. 9(16). 2791–2794. 31 indexed citations
8.
9.
Elliott, Richard L., Keith B. Ryther, David J. Anderson, et al.. (1998). ChemInform Abstract: Novel 2‐(2′‐Furo[3,2‐b]pyridinyl) Pyrrolidines: Potent Neuronal Nicotinic Acetylcholine Receptor Ligands.. ChemInform. 29(10). 1 indexed citations
10.
Briggs, Clark A., David J. Anderson, Jorge D. Brioni, et al.. (1997). Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo. Pharmacology Biochemistry and Behavior. 57(1-2). 231–241. 171 indexed citations
11.
Sullivan, James P., Diana L. Donnelly‐Roberts, David J. Anderson, et al.. (1997). ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties. Journal of Pharmacology and Experimental Therapeutics. 283(1). 235–246. 70 indexed citations
12.
Elliott, Richard L., Keith B. Ryther, David J. Anderson, et al.. (1997). Novel 2-(2′-furo[3,2-b]pyridinyl) pyrrolidines: potent neuronal nicotinic acetylcholine receptor ligands. Bioorganic & Medicinal Chemistry Letters. 7(21). 2703–2708. 26 indexed citations
13.
14.
15.
Elliott, Richard L., Hana Kopecka, David Gunn, et al.. (1996). 2-(Aryloxymethyl) azacyclic analogues as novel nicotinic acetylcholine receptor (nAChR) ligands. Bioorganic & Medicinal Chemistry Letters. 6(19). 2283–2288. 18 indexed citations
16.
Elliott, Richard L., Keith B. Ryther, David J. Anderson, et al.. (1995). Phenyl pyrrolidine analogues as potent nicotinic acetylcholine receptor (nAChR) ligands. Bioorganic & Medicinal Chemistry Letters. 5(9). 991–996. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marietta Piattoni-Kaplan Breakdown of academic impact, for papers by James T. Wasicak Breakdown of academic impact, for papers by Ashok Tehim Breakdown of academic impact, for papers by Terry A. Hauser Breakdown of academic impact, for papers by Christopher G. V. Sharples Breakdown of academic impact, for papers by Agripina G. Deaciuc Breakdown of academic impact, for papers by Anatoly Mazurov Breakdown of academic impact, for papers by William Glassco Breakdown of academic impact, for papers by Vladimir P. Grinevich Breakdown of academic impact, for papers by Brian J. Lavey
Rankless by CCL
2026